In previous studies of single i.d. administration of either GM-CSF or CpG, we found evidence for antimelanoma immune potentiation of the primary tumor site and its lymphatic drainage area through the boosting of tumor-specific CD8+ T cells [11, 12]. This evidence concerns the gene CSF2 and neoplasm.